Pharmacokinetics, safety, and tolerability of dispersible and
4.8
$ 12.99
In stock
(561)
Product Description
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial - ScienceDirect
Dolutegravir, C20H19F2N3O5
Pharmacokinetics and safety of dispersible and immediate release FDC abacavir/dolutegravir/lamivudine in children with HIV weighing '¥14 kg: preliminary results from IMPAACT 2019
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial - ScienceDirect
Population Pharmacokinetics of Cabotegravir in Healthy Adult Subjects and HIV-1 Infected Patients Following Administration of Oral Tablet and Long-Acting Intramuscular Injection
The paediatric pipeline 2017, HTB
Microorganisms, Free Full-Text
Understanding the pharmacokinetics of Coartem®
Liposomal formulations for inhalation
EX-99.1
/origin-imgresizer.eurosport.com/2022/11/28/3499275-71332669-640-480.jpg)
